Effect of sirolimus on coagulopathy of slow‐flow vascular malformations

Abstract

This study suggests that sirolimus improves coagulopathy in slow-flow vascular malformations, as evidenced by reduced D-dimer levels. Improvement in LIC symptoms also correlates with sirolimus-corrected coagulopathy.